Costa Rica vs Ireland: Prevalence of anemia among women of reproductive age
Costa Rica
13.7%
in 2023
Ireland
14.0%
in 2023
Costa Rica rank
184th
Ireland rank
181st
Prevalence of anemia among women of reproductive age over time
- Costa Rica
- Ireland
How they compare
Ireland currently reports 14.0% against 13.7% in Costa Rica, a difference of 0.3%.
The two have swapped places 1 time across 24 shared years of data; in 2000 it was Costa Rica ahead.
Costa Rica ranks 184th and Ireland ranks 181st of 192 countries.
Across the 3 decades both report, Costa Rica averaged higher in 1 and Ireland in 2.
Head to head by decade
| Decade | Costa Rica | Ireland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.9% | 11.1% | 1.8% | Costa Rica |
| 2010s | 10.6% | 11.8% | 1.2% | Ireland |
| 2020s | 12.8% | 13.3% | 0.6% | Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of anemia among women of reproductive age, Costa Rica or Ireland?
- Ireland, at 14.0% against 13.7% in Costa Rica as of 2023.
- What is the difference in prevalence of anemia among women of reproductive age between Costa Rica and Ireland?
- 0.3%, with Ireland ahead.
- How many years of comparable data are there for Costa Rica and Ireland?
- 24 years are reported by both, from 2000 to 2023.
- How do Costa Rica and Ireland rank globally for prevalence of anemia among women of reproductive age?
- Costa Rica ranks 184th and Ireland ranks 181st of 192 countries.
- Where does this data come from?
- Global Health Observatory Data Repository/World Health Statistics, World Health Organization (WHO), published as Prevalence of anemia among women of reproductive age (% of women ages 15-49). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of anemia among women of reproductive age refers to the combined prevalence of both non-pregnant with haemoglobin levels below 12 g/dL and pregnant women with haemoglobin levels below 11 g/dL.